Safety and immunogenicity of a plant-derived rotavirus-like particle vaccine in adults, toddlers and infants

Development and characterization of a plant-derived rotavirus-like particle vaccine

(2021) Natsuki Kurokawa et al.   VACCINE

Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial

(2020) Michelle J Groome et al.   LANCET INFECTIOUS DISEASES

Recent Progress on the Versatility of Virus-Like Particles

(2020) Ciying Qian et al.   Vaccines

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?

(2019) A.D. Steele et al.   Human Vaccines & Immunotherapeutics

Current and new rotavirus vaccines

(2019) Rachel M. Burke et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials

(2019) Andrew Clark et al.   LANCET INFECTIOUS DISEASES

Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults

(2019) Stéphane Pillet et al.   PLoS One

DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination

(2019) Yahiya Y. Syed   PEDIATRIC DRUGS

The future control of rotavirus disease: Can live oral vaccines alone solve the rotavirus problem?

(2018) Roger I. Glass et al.   VACCINE

Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality From Diarrhea

(2017) Eleanor Burnett et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial

(2017) Michelle J Groome et al.   LANCET INFECTIOUS DISEASES

Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015

(2017) Christopher Troeger et al.   LANCET INFECTIOUS DISEASES

Rotavirus virus-like particles (RV-VLPs) vaccines: An update

(2017) Harish Changotra et al.   REVIEWS IN MEDICAL VIROLOGY

VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans

(2017) Nitya Nair et al.   Science Translational Medicine

The rotavirus vaccine development pipeline

(2017) Carl D. Kirkwood et al.   VACCINE

12-Item Pruritus Severity Scale: Development and Validation of New Itch Severity Questionnaire

(2017) Adam Reich et al.   Biomed Research International

A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults

(2016) Stéphane Pillet et al.   CLINICAL IMMUNOLOGY

Molecular pharming — VLPs made in plants

(2016) Johanna Marsian et al.   CURRENT OPINION IN BIOTECHNOLOGY

The Immunogenicity and Safety of a Combined DTaP-IPV//Hib Vaccine Compared with Individual DTaP-IPV and Hib (PRP~T) Vaccines: a Randomized Clinical Trial in South Korean Infants

(2016) Jin Han Kang et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment

(2016) G. P. Lomonossoff et al.   SCIENCE

Engineering virus-like particles as vaccine platforms

(2016) Kathryn M Frietze et al.   Current Opinion in Virology

Rotavirus vaccines: a story of success

(2015) H. Kollaritsch et al.   CLINICAL MICROBIOLOGY AND INFECTION

Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014

(2015) Emilie Karafillakis et al.   VACCINE

Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets

(2015) S. Pillet et al.   VACCINE

Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: Is there evidence of strain selection from vaccine pressure?

(2014) Renáta Dóró et al.   INFECTION GENETICS AND EVOLUTION

Strain diversity plays no major role in the varying efficacy of rotavirus vaccines: An overview

(2014) Daniel E. Velasquez et al.   INFECTION GENETICS AND EVOLUTION

Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings

(2014) E Clarke et al.   Mucosal Immunology

Risk of Intussusception after Monovalent Rotavirus Vaccination

(2014) Eric S. Weintraub et al.   NEW ENGLAND JOURNAL OF MEDICINE

Circulating rotavirus-specific T cells have a poor functional profile

(2014) Miguel Parra et al.   VIROLOGY

Rotavirus vaccines

(2014) Catherine Yen et al.   Human Vaccines & Immunotherapeutics

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

(2010) K Zaman et al.   LANCET

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

(2010) George E Armah et al.   LANCET

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

(2010) Shabir A. Madhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza

(2010) Marc-André D’Aoust et al.   PLANT BIOTECHNOLOGY JOURNAL

Oral Rotavirus Vaccines: How Well Will They Work Where They Are Needed Most?

(2009) Manish Patel et al.   JOURNAL OF INFECTIOUS DISEASES

Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments

(2008) Jelle Matthijnssens et al.   ARCHIVES OF VIROLOGY